ClinicalTrials.gg
CompletedNCT06578260Updated Oct 27, 2026

Support Groups - a Model for Social Inclusion and Reduction of Bullying in School

An interventional study of Peer support groups with a solution-focused approach in Bullying, sponsored by Oslo Metropolitan University. Completed at 1 site in Norway. Open to participants aged 10 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-27.

Sponsored by Oslo Metropolitan University · Not applicable, Interventional, and Health services research

Updated Oct 27, 2026Now CompletedPrimary completion moved+4 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
3,188
Allocation
Randomized
Ages
10 Years to 12 Years
Sex
All
01

Study summary

Study Title: Support Groups - a model for social inclusion and reduction of bullying in school Study Design: Cluster Randomized Controlled trial (CRCT) Objective: To investigate the effectiveness of a support group intervention using a solution-focused approach among school children in 5th-7th grade in southeastern Norway Intervention: Peer support groups with a solution-focused approach Study Population: School Children

Read the detailed description

The primary objective of this study is to investigate the effectiveness of a support group intervention using a solution-focused approach in reducing bullying, enhancing mental health, improving quality of life, and increasing general self-efficacy among school children in 5th-7th grade. Investigators hypothesize that the awareness of bullying created by the intervention, and the empowerment of children as contributors to the solution, will generate positive ripple effects benefiting all children in the intervention schools. Furthermore, investigators hypothesize that children with a peer support group will exhibit lower levels of bullying, improved mental health, better quality of life, and increased general self-efficacy after the intervention compared to their baseline levels. Investigators expect these effects to persist even after 3 and 6 months. Aligned with the cluster RCT, the investigators will undertake a parallel process evaluation to assess the extent of the intervention coverage, whether the intervention was implemented according to the protocol, and identify factors that hinder or aid the implementation of a support group intervention. For the process evaluation, investigators will use the framework presented by the Medical Research Council guidelines focusing on the implementation (what is implemented and how), the mechanisms of impact (how the delivered intervention produces change), and the context (how the context affects implementation and outcomes).

02

Conditions studied

  • Bullying

Browse trials for

Keywords

  • Supportgroups
  • schoolchildren
  • solution-focused-approach
03

In context

Bullying

57 studies on the registry are indexed under Bullying; 9 are open to participants now.

This study's enrollment of 3,188 is above the median of 228 across 51 interventional studies indexed under Bullying.

Browse Bullying studies →

Lead sponsor

Oslo Metropolitan University is the lead sponsor of 64 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Primary Schools with more than 200 students
  • Public Health Nurse employed in a 50% position or more

Exclusion criteria

Exclusion Criteria:

  • Primary Schools with less than 200 students
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
3,188 participants (actual)

Study arms

  • Experimental
    The effect and outcomes in the intervention schools

    The intervention schools will use the Support Group intervention regarding bullying and exclusion.

    Behavioral: Peer support groups with a solution-focused approach

  • No intervention
    The outcomes in the control schools

    The control schools will implement the same measures as they normally do regarding bullying and exclusion.

Interventions

  • BehavioralPeer support groups with a solution-focused approach

    To investigate the effectiveness of a support group intervention using a solution-focused approach among school children in 5th-7th grade in southeastern Norway

06

What researchers measure

Primary outcomes

  1. Bullying- change from baseline in bullying using the Olweus questionnaire at end of intervention, 3 months and 6 months after end of intervention on individual level at intervention schools.

    The Olweus questionnaire is a validated self-reported questionnaire that may be answered from ; Not at all (no bullying), one or seldom, 2-3 times in the months or about one times a week or more (worst possible bullying score) (Olweus, 2013).

    Time frame: Baseline, Week 6, Week 18 and Week 32

  2. Mental health- change from baseline in mental health using the Strength and Difficulties Questionnaires (SDQ), at end of intervention, 3 months and 6 months after end of intervention on individual level at intervention schools.

    The Strength and Difficulties Questionnaires (SDQ) is a validated self-reported questionnaire which consists of 25-items (Goodman, 1999). The questionnaires measure emotional problems, conduct problems, hyperactivity, peer problems, pro-social behavior and impact score. The questionnaires may be answered form "not true" (lowest possible score) to "certainly true" (highest possible score). A high total difficulties score indicates that the individual is experiencing a high level of difficulties, while a low score indicates a low level of difficulties.

    Time frame: Baseline, Week 6, Week 18 and Week 32

  3. Self-efficacy-change from baseline in self-efficacy using the General self-efficacy scale, at end of intervention, 3 months and 6 months after end of intervention on individual level at intervention schools.

    The General self-efficacy scale is a self-administered form with five response categories from "Completely agrees to "not agrees". The scale measures the belief in self-efficacy. Highest scores indicate best self-efficacy (Bandura, 1997).

    Time frame: Baseline, Week 6, Week 18 and Week 32

  4. Quality of life-change from baseline in quality of life using the Kidscreen -10, 4 months after baseline, end of intervention and 6 months after end of intervention in both intervention and control schools in 5th to 7th grade on class level.

    The KIDSCREEN-10 index is the shortest version of the KIDSCREEN questionnaires and measures general health-related quality of life (Detmar, Bruil, Ravens-Sieberer, Gosch \& Bisegger, 2006). Possible scores range from "not at all" or "never" (lowest possible score) to "a high degree" or "always" (highest possible score).

    Time frame: Baseline, Week 17, Week 30 and Week 56

  5. Class environment- change from baseline using the Norwegian student survey (Elevundersøkelsen), 4 months, end of intervention and 6 months after end of intervention in both intervention and control schools in 5th to 7th grade on class level.

    To measure class environment all children in 5th to 7th grade will complete the Norwegian student survey (Elevundersøkelsen, UDIR 2023). The survey which asking among other things about bullying and inclusion in the school environment and peer relationship.

    Time frame: Baseline, Week 17, Week 30 and Week 56

07

Study locations

1 site
  • OsloMet
    Oslo, Norway, Norway
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2024 to primary completion in May 2026, 18 months.

Of 36 non-industry interventional studies with no phase under Bullying, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 18. This study's 18 months is above that.

Counting every sponsor, half of 40 studies reached it within 11 months; a quarter within 4 and three quarters within 20.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 27, 2026: primary completion Dec 2025 → May 2026 and completion Aug 2028 → May 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 16, 2024
First posted
Aug 29, 2024
StartActual
Nov 1, 2024
Primary completionActual
May 21, 2026was Dec 2025
CompletionActual
May 21, 2026was Aug 2028
Last update
Oct 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 27, 2026
Sites
1 site added, 1 site removed
Show site
  • OsloMet · Oslo, Norway
Show 1 removed
  • OsloMet · Oslo, Norway
Oct 27, 2026
Primary completion
Dec 1, 2025→May 21, 2026 (actual)
Oct 27, 2026
Study completion
Aug 1, 2028→May 21, 2026 (actual)
Oct 27, 2026
Enrollment
1586 (estimated)→3188 (actual)
Oct 27, 2026
Show all 1 update
  1. Oct 27, 2026
    Recruiting→Completed
    1 site added, 1 site removed
    Show site
    • OsloMet · Oslo, Norway
    Show 1 removed
    • OsloMet · Oslo, Norway
    Primary completion Dec 1, 2025→May 21, 2026 (now actual)
    Study completion Aug 1, 2028→May 21, 2026 (now actual)
    Enrollment 1586 (estimated)→3188 (actual)
    + 3 other changes: responsible party, contact details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06578260
Lead sponsor
Oslo Metropolitan University
Responsible party
Sponsor
First posted
Aug 29, 2024
Start date
Nov 1, 2024
Primary completion
May 21, 2026
Completion
May 21, 2026
Last update
Oct 27, 2026

Study contacts

Lisbeth Valla, Phd
principal investigator · OsloMet

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion